
### [MONDO:0004603](http://purl.obolibrary.org/obo/MONDO_0004603)
**Label:** collagenopathy

**Subclasses:** [MONDO:0016202](http://purl.obolibrary.org/obo/MONDO_0016202) (autosomal dominant rhegmatogenous retinal detachment), [MONDO:0014544](http://purl.obolibrary.org/obo/MONDO_0014544) (osteogenesis imperfecta type 16), [MONDO:0012287](http://purl.obolibrary.org/obo/MONDO_0012287) (Stickler syndrome, type i, nonsyndromic ocular), [MONDO:0011670](http://purl.obolibrary.org/obo/MONDO_0011670) (Ehlers-Danlos syndrome due to tenascin-X deficiency), [MONDO:0016002](http://purl.obolibrary.org/obo/MONDO_0016002) (Ehlers-Danlos syndrome, kyphoscoliotic type), [MONDO:0008146](http://purl.obolibrary.org/obo/MONDO_0008146) (osteogenesis imperfecta type 1), [MONDO:0016085](http://purl.obolibrary.org/obo/MONDO_0016085) (Cole-Carpenter syndrome), [MONDO:0009158](http://purl.obolibrary.org/obo/MONDO_0009158) (Ehlers-Danlos syndrome, fibronectinemic type), [MONDO:0008147](http://purl.obolibrary.org/obo/MONDO_0008147) (osteogenesis imperfecta type 2), [MONDO:0009159](http://purl.obolibrary.org/obo/MONDO_0009159) (Ehlers-Danlos syndrome, cardiac valvular type), [MONDO:0008148](http://purl.obolibrary.org/obo/MONDO_0008148) (osteogenesis imperfecta type 4), [MONDO:0008149](http://purl.obolibrary.org/obo/MONDO_0008149) (osteogenesis imperfecta with opalescent teeth, blue sclerae and wormian bones but without fractures), [MONDO:0008702](http://purl.obolibrary.org/obo/MONDO_0008702) (achondrogenesis type II), [MONDO:0007528](http://purl.obolibrary.org/obo/MONDO_0007528) (Ehlers-Danlos syndrome, autosomal dominant, type unspecified), [MONDO:0007527](http://purl.obolibrary.org/obo/MONDO_0007527) (Ehlers-Danlos syndrome, periodontitis type), [MONDO:0007526](http://purl.obolibrary.org/obo/MONDO_0007526) (Ehlers-Danlos syndrome progeroid type), [MONDO:0007525](http://purl.obolibrary.org/obo/MONDO_0007525) (Ehlers-Danlos syndrome, arthrochalasis type), [MONDO:0007524](http://purl.obolibrary.org/obo/MONDO_0007524) (autosomal dominant Ehlers-Danlos syndrome, vascular type), [MONDO:0007204](http://purl.obolibrary.org/obo/MONDO_0007204) (Cole-Carpenter syndrome 1), [MONDO:0007842](http://purl.obolibrary.org/obo/MONDO_0007842) (Ehlers-Danlos syndrome type 11), [MONDO:0007523](http://purl.obolibrary.org/obo/MONDO_0007523) (type III Ehlers-Danlos syndrome), [MONDO:0007885](http://purl.obolibrary.org/obo/MONDO_0007885) (Legg-Calve-Perthes disease), [MONDO:0007522](http://purl.obolibrary.org/obo/MONDO_0007522) (Ehlers-Danlos syndrome, classic type), [MONDO:0020066](http://purl.obolibrary.org/obo/MONDO_0020066) (Ehlers-Danlos syndrome), [MONDO:0007562](http://purl.obolibrary.org/obo/MONDO_0007562) (multiple epiphyseal dysplasia, Beighton type), [MONDO:0012126](http://purl.obolibrary.org/obo/MONDO_0012126) (familial avascular necrosis of femoral head), [MONDO:0010586](http://purl.obolibrary.org/obo/MONDO_0010586) (X-linked Ehlers-Danlos syndrome), [MONDO:0014029](http://purl.obolibrary.org/obo/MONDO_0014029) (osteogenesis imperfecta type 14), [MONDO:0014701](http://purl.obolibrary.org/obo/MONDO_0014701) (spondyloepiphyseal dysplasia, Stanescu type), [MONDO:0007160](http://purl.obolibrary.org/obo/MONDO_0007160) (Stickler syndrome type 1), [MONDO:0012206](http://purl.obolibrary.org/obo/MONDO_0012206) (Czech dysplasia, metatarsal type), [MONDO:0013459](http://purl.obolibrary.org/obo/MONDO_0013459) (osteogenesis imperfecta type 10), [MONDO:0008490](http://purl.obolibrary.org/obo/MONDO_0008490) (Stickler syndrome type 3), [MONDO:0019669](http://purl.obolibrary.org/obo/MONDO_0019669) (hypochondrogenesis), [MONDO:0012592](http://purl.obolibrary.org/obo/MONDO_0012592) (osteogenesis imperfecta type 11), [MONDO:0019348](http://purl.obolibrary.org/obo/MONDO_0019348) (Ehlers-Danlos syndrome with periventricular heterotopia), [MONDO:0012591](http://purl.obolibrary.org/obo/MONDO_0012591) (osteogenesis imperfecta type 5), [MONDO:0011142](http://purl.obolibrary.org/obo/MONDO_0011142) (Ehlers-Danlos syndrome, musculocontractural type), [MONDO:0014573](http://purl.obolibrary.org/obo/MONDO_0014573) (Cole-Carpenter syndrome 2), [MONDO:0016470](http://purl.obolibrary.org/obo/MONDO_0016470) (Ehlers-Danlos/osteogenesis imperfecta syndrome), [MONDO:0009226](http://purl.obolibrary.org/obo/MONDO_0009226) (fibrochondrogenesis 1), [MONDO:0008975](http://purl.obolibrary.org/obo/MONDO_0008975) (otospondylomegaepiphyseal dysplasia), [MONDO:0007895](http://purl.obolibrary.org/obo/MONDO_0007895) (Platyspondylic dysplasia, Torrance type), [MONDO:0013924](http://purl.obolibrary.org/obo/MONDO_0013924) (osteogenesis imperfecta type 13), [MONDO:0013605](http://purl.obolibrary.org/obo/MONDO_0013605) (brittle cornea syndrome 2), [MONDO:0012873](http://purl.obolibrary.org/obo/MONDO_0012873) (Ehlers-Danlos syndrome, spondylocheirodysplastic type), [MONDO:0012114](http://purl.obolibrary.org/obo/MONDO_0012114) (Ehlers-Danlos syndrome, Beasley-Cohen type), [MONDO:0014139](http://purl.obolibrary.org/obo/MONDO_0014139) (Ehlers-Danlos syndrome, progeroid type, 2), [MONDO:0013800](http://purl.obolibrary.org/obo/MONDO_0013800) (Ehlers-Danlos syndrome, kyphoscoliotic and deafness type), [MONDO:0011493](http://purl.obolibrary.org/obo/MONDO_0011493) (Stickler syndrome type 2), [MONDO:0017314](http://purl.obolibrary.org/obo/MONDO_0017314) (Ehlers-Danlos syndrome, vascular type), [MONDO:0012581](http://purl.obolibrary.org/obo/MONDO_0012581) (osteogenesis imperfecta type 8), [MONDO:0016469](http://purl.obolibrary.org/obo/MONDO_0016469) (Ehlers-Danlos syndrome, vascular-like type), [MONDO:0013795](http://purl.obolibrary.org/obo/MONDO_0013795) (fibrochondrogenesis 2), [MONDO:0018601](http://purl.obolibrary.org/obo/MONDO_0018601) (autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome), [MONDO:0019019](http://purl.obolibrary.org/obo/MONDO_0019019) (osteogenesis imperfecta), [MONDO:0014086](http://purl.obolibrary.org/obo/MONDO_0014086) (osteogenesis imperfecta type 15), [MONDO:0011496](http://purl.obolibrary.org/obo/MONDO_0011496) (mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis), [MONDO:0011375](http://purl.obolibrary.org/obo/MONDO_0011375) (brittle bone disorder), [MONDO:0016068](http://purl.obolibrary.org/obo/MONDO_0016068) (fibrochondrogenesis), [MONDO:0007949](http://purl.obolibrary.org/obo/MONDO_0007949) (Marshall syndrome), [MONDO:0020521](http://purl.obolibrary.org/obo/MONDO_0020521) (Ehlers-Danlos syndrome type 7A), [MONDO:0020522](http://purl.obolibrary.org/obo/MONDO_0020522) (Ehlers-Danlos syndrome type 7B), [MONDO:0007987](http://purl.obolibrary.org/obo/MONDO_0007987) (Kniest dysplasia), [MONDO:0002014](http://purl.obolibrary.org/obo/MONDO_0002014) (autosomal recessive Ehlers-Danlos syndrome, vascular type), [MONDO:0013515](http://purl.obolibrary.org/obo/MONDO_0013515) (osteogenesis imperfecta type 6), [MONDO:0009161](http://purl.obolibrary.org/obo/MONDO_0009161) (Ehlers-Danlos syndrome, dermatosparaxis type), [MONDO:0010195](http://purl.obolibrary.org/obo/MONDO_0010195) (Weissenbacher- Zweymuller syndrome), [MONDO:0019568](http://purl.obolibrary.org/obo/MONDO_0019568) (Ehlers-Danlos syndrome type 2), [MONDO:0008471](http://purl.obolibrary.org/obo/MONDO_0008471) (spondyloepiphyseal dysplasia congenita), [MONDO:0014236](http://purl.obolibrary.org/obo/MONDO_0014236) (Ehlers-Danlos syndrome, musculocontractural type 2), [MONDO:0009242](http://purl.obolibrary.org/obo/MONDO_0009242) (brittle cornea syndrome), [MONDO:0019687](http://purl.obolibrary.org/obo/MONDO_0019687) (type 11 collagen-related bone disorder), [MONDO:0019567](http://purl.obolibrary.org/obo/MONDO_0019567) (Ehlers-Danlos syndrome type 1), [MONDO:0010078](http://purl.obolibrary.org/obo/MONDO_0010078) (Spondyloperipheral dysplasia-short ulna syndrome), [MONDO:0013460](http://purl.obolibrary.org/obo/MONDO_0013460) (osteogenesis imperfecta type 12), [MONDO:0014672](http://purl.obolibrary.org/obo/MONDO_0014672) (osteogenesis imperfecta type 17), [MONDO:0019686](http://purl.obolibrary.org/obo/MONDO_0019686) (type 2 collagen-related bone disorder), [MONDO:0008476](http://purl.obolibrary.org/obo/MONDO_0008476) (spondyloepimetaphyseal dysplasia, Strudwick type), [MONDO:0004803](http://purl.obolibrary.org/obo/MONDO_0004803) (disseminated eosinophilic collagen disease), [MONDO:0008478](http://purl.obolibrary.org/obo/MONDO_0008478) (spondylometaphyseal dysplasia, Schmidt type), [MONDO:0008479](http://purl.obolibrary.org/obo/MONDO_0008479) (spondylometaphyseal dysplasia, 'corner fracture' type), [MONDO:0009804](http://purl.obolibrary.org/obo/MONDO_0009804) (osteogenesis imperfecta type 3), [MONDO:0009805](http://purl.obolibrary.org/obo/MONDO_0009805) (osteogenesis imperfecta type 9), [MONDO:0014954](http://purl.obolibrary.org/obo/MONDO_0014954) (Ehlers-Danlos syndrome, periodontal type 2 Edspd2), [MONDO:0012536](http://purl.obolibrary.org/obo/MONDO_0012536) (osteogenesis imperfecta type 7), 

**Mapped go classes:** [GO:0060363](http://purl.obolibrary.org/obo/GO_0060363) (cranial suture morphogenesis), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0015672](http://purl.obolibrary.org/obo/GO_0015672) (monovalent inorganic cation transport), [GO:0035284](http://purl.obolibrary.org/obo/GO_0035284) (brain segmentation), [GO:0022408](http://purl.obolibrary.org/obo/GO_0022408) (negative regulation of cell-cell adhesion), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0021797](http://purl.obolibrary.org/obo/GO_0021797) (forebrain anterior/posterior pattern specification), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0044794](http://purl.obolibrary.org/obo/GO_0044794) (positive regulation by host of viral process), [GO:0021551](http://purl.obolibrary.org/obo/GO_0021551) (central nervous system morphogenesis), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0045887](http://purl.obolibrary.org/obo/GO_0045887) (positive regulation of synaptic growth at neuromuscular junction), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0004656](http://purl.obolibrary.org/obo/GO_0004656) (procollagen-proline 4-dioxygenase activity), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:1990403](http://purl.obolibrary.org/obo/GO_1990403) (embryonic brain development), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0071805](http://purl.obolibrary.org/obo/GO_0071805) (potassium ion transmembrane transport), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0061448](http://purl.obolibrary.org/obo/GO_0061448) (connective tissue development), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0014902](http://purl.obolibrary.org/obo/GO_0014902) (myotube differentiation), [GO:0070278](http://purl.obolibrary.org/obo/GO_0070278) (extracellular matrix constituent secretion), [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0060023](http://purl.obolibrary.org/obo/GO_0060023) (soft palate development), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0046873](http://purl.obolibrary.org/obo/GO_0046873) (metal ion transmembrane transporter activity), [GO:0048018](http://purl.obolibrary.org/obo/GO_0048018) (receptor ligand activity), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0003433](http://purl.obolibrary.org/obo/GO_0003433) (chondrocyte development involved in endochondral bone morphogenesis), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0030001](http://purl.obolibrary.org/obo/GO_0030001) (metal ion transport), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:2001223](http://purl.obolibrary.org/obo/GO_2001223) (negative regulation of neuron migration), [GO:0030127](http://purl.obolibrary.org/obo/GO_0030127) (COPII vesicle coat), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0035250](http://purl.obolibrary.org/obo/GO_0035250) (UDP-galactosyltransferase activity), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0046525](http://purl.obolibrary.org/obo/GO_0046525) (xylosylprotein 4-beta-galactosyltransferase activity), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006829](http://purl.obolibrary.org/obo/GO_0006829) (zinc II ion transport), [GO:0017151](http://purl.obolibrary.org/obo/GO_0017151) (DEAD/H-box RNA helicase binding), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0018126](http://purl.obolibrary.org/obo/GO_0018126) (protein hydroxylation), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0005790](http://purl.obolibrary.org/obo/GO_0005790) (smooth endoplasmic reticulum), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0006882](http://purl.obolibrary.org/obo/GO_0006882) (cellular zinc ion homeostasis), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0008146](http://purl.obolibrary.org/obo/GO_0008146) (sulfotransferase activity), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:0000413](http://purl.obolibrary.org/obo/GO_0000413) (protein peptidyl-prolyl isomerization), [GO:0000412](http://purl.obolibrary.org/obo/GO_0000412) (histone peptidyl-prolyl isomerization), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0005797](http://purl.obolibrary.org/obo/GO_0005797) (Golgi medial cisterna), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005788](http://purl.obolibrary.org/obo/GO_0005788) (endoplasmic reticulum lumen), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0070365](http://purl.obolibrary.org/obo/GO_0070365) (hepatocyte differentiation), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0001867](http://purl.obolibrary.org/obo/GO_0001867) (complement activation, lectin pathway), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0014814](http://purl.obolibrary.org/obo/GO_0014814) (axon regeneration at neuromuscular junction), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0051604](http://purl.obolibrary.org/obo/GO_0051604) (protein maturation), [GO:0071577](http://purl.obolibrary.org/obo/GO_0071577) (zinc II ion transmembrane transport), [GO:0034663](http://purl.obolibrary.org/obo/GO_0034663) (endoplasmic reticulum chaperone complex), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:2000050](http://purl.obolibrary.org/obo/GO_2000050) (regulation of non-canonical Wnt signaling pathway), [GO:0010592](http://purl.obolibrary.org/obo/GO_0010592) (positive regulation of lamellipodium assembly), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0021588](http://purl.obolibrary.org/obo/GO_0021588) (cerebellum formation), [GO:1904948](http://purl.obolibrary.org/obo/GO_1904948) (midbrain dopaminergic neuron differentiation), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021592](http://purl.obolibrary.org/obo/GO_0021592) (fourth ventricle development), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0048570](http://purl.obolibrary.org/obo/GO_0048570) (notochord morphogenesis), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0035989](http://purl.obolibrary.org/obo/GO_0035989) (tendon development), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0033688](http://purl.obolibrary.org/obo/GO_0033688) (regulation of osteoblast proliferation), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:1990909](http://purl.obolibrary.org/obo/GO_1990909) (Wnt signalosome), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:1904954](http://purl.obolibrary.org/obo/GO_1904954) (canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0045747](http://purl.obolibrary.org/obo/GO_0045747) (positive regulation of Notch signaling pathway), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0043568](http://purl.obolibrary.org/obo/GO_0043568) (positive regulation of insulin-like growth factor receptor signaling pathway), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:2000738](http://purl.obolibrary.org/obo/GO_2000738) (positive regulation of stem cell differentiation), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005528](http://purl.obolibrary.org/obo/GO_0005528) (FK506 binding), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0050777](http://purl.obolibrary.org/obo/GO_0050777) (negative regulation of immune response), [GO:0050655](http://purl.obolibrary.org/obo/GO_0050655) (dermatan sulfate proteoglycan metabolic process), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0043332](http://purl.obolibrary.org/obo/GO_0043332) (mating projection tip), [GO:0008378](http://purl.obolibrary.org/obo/GO_0008378) (galactosyltransferase activity), [GO:0008499](http://purl.obolibrary.org/obo/GO_0008499) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0005592](http://purl.obolibrary.org/obo/GO_0005592) (collagen type XI trimer), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0042770](http://purl.obolibrary.org/obo/GO_0042770) (signal transduction in response to DNA damage), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0000578](http://purl.obolibrary.org/obo/GO_0000578) (embryonic axis specification), [GO:0022004](http://purl.obolibrary.org/obo/GO_0022004) (midbrain-hindbrain boundary maturation during brain development), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0005109](http://purl.obolibrary.org/obo/GO_0005109) (frizzled binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0010812](http://purl.obolibrary.org/obo/GO_0010812) (negative regulation of cell-substrate adhesion), [GO:0032964](http://purl.obolibrary.org/obo/GO_0032964) (collagen biosynthetic process), [GO:0032963](http://purl.obolibrary.org/obo/GO_0032963) (collagen metabolic process), [GO:0036520](http://purl.obolibrary.org/obo/GO_0036520) (astrocyte-dopaminergic neuron signaling), [GO:1901874](http://purl.obolibrary.org/obo/GO_1901874) (negative regulation of post-translational protein modification), [GO:0006457](http://purl.obolibrary.org/obo/GO_0006457) (protein folding), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0050840](http://purl.obolibrary.org/obo/GO_0050840) (extracellular matrix binding), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0002063](http://purl.obolibrary.org/obo/GO_0002063) (chondrocyte development), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0048664](http://purl.obolibrary.org/obo/GO_0048664) (neuron fate determination), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0010595](http://purl.obolibrary.org/obo/GO_0010595) (positive regulation of endothelial cell migration), [GO:0015269](http://purl.obolibrary.org/obo/GO_0015269) (calcium-activated potassium channel activity), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0061184](http://purl.obolibrary.org/obo/GO_0061184) (positive regulation of dermatome development), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer), [GO:0060536](http://purl.obolibrary.org/obo/GO_0060536) (cartilage morphogenesis), [GO:0007520](http://purl.obolibrary.org/obo/GO_0007520) (myoblast fusion), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0000324](http://purl.obolibrary.org/obo/GO_0000324) (fungal-type vacuole), [GO:0005586](http://purl.obolibrary.org/obo/GO_0005586) (collagen type III trimer), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0060414](http://purl.obolibrary.org/obo/GO_0060414) (aorta smooth muscle tissue morphogenesis), [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0047220](http://purl.obolibrary.org/obo/GO_0047220) (galactosylxylosylprotein 3-beta-galactosyltransferase activity), [GO:0030514](http://purl.obolibrary.org/obo/GO_0030514) (negative regulation of BMP signaling pathway), [GO:0003831](http://purl.obolibrary.org/obo/GO_0003831) (beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0001537](http://purl.obolibrary.org/obo/GO_0001537) (N-acetylgalactosamine 4-O-sulfotransferase activity), [GO:0001658](http://purl.obolibrary.org/obo/GO_0001658) (branching involved in ureteric bud morphogenesis), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0071425](http://purl.obolibrary.org/obo/GO_0071425) (hematopoietic stem cell proliferation), [GO:0018400](http://purl.obolibrary.org/obo/GO_0018400) (peptidyl-proline hydroxylation to 3-hydroxy-L-proline), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0030512](http://purl.obolibrary.org/obo/GO_0030512) (negative regulation of transforming growth factor beta receptor signaling pathway), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0022604](http://purl.obolibrary.org/obo/GO_0022604) (regulation of cell morphogenesis), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:1903204](http://purl.obolibrary.org/obo/GO_1903204) (negative regulation of oxidative stress-induced neuron death), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0016051](http://purl.obolibrary.org/obo/GO_0016051) (carbohydrate biosynthetic process), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0000149](http://purl.obolibrary.org/obo/GO_0000149) (SNARE binding), [GO:0005048](http://purl.obolibrary.org/obo/GO_0005048) (signal sequence binding), [GO:0060037](http://purl.obolibrary.org/obo/GO_0060037) (pharyngeal system development), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0022037](http://purl.obolibrary.org/obo/GO_0022037) (metencephalon development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0047757](http://purl.obolibrary.org/obo/GO_0047757) (chondroitin-glucuronate 5-epimerase activity), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0030579](http://purl.obolibrary.org/obo/GO_0030579) (ubiquitin-dependent SMAD protein catabolic process), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0019797](http://purl.obolibrary.org/obo/GO_0019797) (procollagen-proline 3-dioxygenase activity), [GO:0030574](http://purl.obolibrary.org/obo/GO_0030574) (collagen catabolic process), [GO:0031545](http://purl.obolibrary.org/obo/GO_0031545) (peptidyl-proline 4-dioxygenase activity), [GO:0016049](http://purl.obolibrary.org/obo/GO_0016049) (cell growth), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0018208](http://purl.obolibrary.org/obo/GO_0018208) (peptidyl-proline modification), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0090110](http://purl.obolibrary.org/obo/GO_0090110) (cargo loading into COPII-coated vesicle), [GO:1903225](http://purl.obolibrary.org/obo/GO_1903225) (negative regulation of endodermal cell differentiation), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0009607](http://purl.obolibrary.org/obo/GO_0009607) (response to biotic stimulus), [GO:0031418](http://purl.obolibrary.org/obo/GO_0031418) (L-ascorbic acid binding), [GO:0030208](http://purl.obolibrary.org/obo/GO_0030208) (dermatan sulfate biosynthetic process), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0031091](http://purl.obolibrary.org/obo/GO_0031091) (platelet alpha granule), [GO:0031092](http://purl.obolibrary.org/obo/GO_0031092) (platelet alpha granule membrane), [GO:0050708](http://purl.obolibrary.org/obo/GO_0050708) (regulation of protein secretion), [GO:0044829](http://purl.obolibrary.org/obo/GO_0044829) (positive regulation by host of viral genome replication), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:0005261](http://purl.obolibrary.org/obo/GO_0005261) (cation channel activity), [GO:0005385](http://purl.obolibrary.org/obo/GO_0005385) (zinc ion transmembrane transporter activity), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005267](http://purl.obolibrary.org/obo/GO_0005267) (potassium channel activity), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0097435](http://purl.obolibrary.org/obo/GO_0097435) (supramolecular fiber organization), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0060061](http://purl.obolibrary.org/obo/GO_0060061) (Spemann organizer formation), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), 

**Class expressions from DL-Learner:**

- Thing 57.21%
- [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer) 51.57%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.39%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 50.39%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.39%
- [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane) 50.39%
- [GO:0005592](http://purl.obolibrary.org/obo/GO_0005592) (collagen type XI trimer) 50.39%
- [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer) 50.39%
- [GO:0005586](http://purl.obolibrary.org/obo/GO_0005586) (collagen type III trimer) 50.39%
- [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer) 50.39%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) and [GO:0044420](http://purl.obolibrary.org/obo/GO_0044420) (extracellular matrix component) 46.30%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) and [GO:0044420](http://purl.obolibrary.org/obo/GO_0044420) (extracellular matrix component) 46.30%
- [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer) and [GO:0044420](http://purl.obolibrary.org/obo/GO_0044420) (extracellular matrix component) 46.30%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 39.67%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 35.75%


